Hypermarcas bet in niche

São Paulo-Hypermarcas will strengthen their investment strategy in specific and regional niches in the pharmaceutical market, stated executives during investor event on Monday (5).
According to the CEO of the company, Claudio Bergamo, of the years to come, especially the improvement in technologies still little explored in the market. "Our focus is to strengthen the capacity for innovation in specific treatments," he said, without giving further details.
The company also provides greater performance in markets where it has little market share, as the southern region of the country, where the index is 9%. In the North and Northeast, that number reaches 21%, according to the company.